Furthermore, an elegant longitudinal study performed in patients with COVID-19 found a correlation between the late-stage pathology in COVID-19 and cytokines linked to the inflammasome pathway, including IL-1β and IL-18 (Lucas et al., 2020). The gene discussed is IL1B; the disease is COVID-19.